BioLineRx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.

CEO

Philip Adam Serlin

CEOPhilip Adam Serlin

Employees

Employees28

Headquarters

Modi'in, HaMerkaz

HeadquartersModi'in, HaMerkaz

Founded

2003

Founded2003

Employees

Employees28

BLRX Key Statistics

Market cap

19.22M

Market cap19.22M

Price-Earnings ratio

-1.62

Price-Earnings ratio-1.62

Dividend yield

—

Dividend yield—

Average volume

31.31K

Average volume31.31K

High today

$4.57

High today$4.57

Low today

$4.43

Low today$4.43

Open price

$4.56

Open price$4.56

Volume

25.82K

Volume25.82K

52 Week high

$35.60

52 Week high$35.60

52 Week low

$2.30

52 Week low$2.30